(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (R)-2-hydroxy-2-phenylacetate

(1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine;hydrochloride

pharmaceutical research compound

(1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine;hydrochloride

pharmaceutical intermediate

(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine

n.a

(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R,3R)-2,3-Dihydroxysuccinate

Active pharmaceutical ingredient

2-(((3aR,4S,6R,6aS)-6-((5-Amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol

Ticagrelor intermediate

2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]ethanol

pharmaceutical intermediate

Ethyl (3R)-piperidine-3-carboxylate--hydrogen chloride (1/1)

Pharmaceutical intermediate for nipecotic acid derivatives

2,3-Dimethyl-4-nitropyridine 1-oxide

Pharmaceutical intermediate